Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jan 31, 2025 | (FY)Jan 31, 2024 | (FY)Jan 31, 2023 | |
|---|---|---|---|
| Operating cash flow (Indirect Method) | |||
| Cash from operating activities | -778.42%-995.68M | -60.50%146.77M | 371.55M |
| Net profit before non-cash adjustment | -112.73%-688.88M | 68.62%-323.82M | ---1.03B |
| Total adjustment of non-cash items | -52.28%256.25M | -56.39%537.04M | --1.23B |
| -Depreciation and amortization | 73.38%330.11M | 32.75%190.4M | --143.42M |
| -Reversal of impairment losses recognized in profit and loss | --0 | 161.90%434.64M | --165.96M |
| -Share of associates | 224.56%151.58M | -95.52%46.7M | --1.04B |
| -Disposal profit | 854.53%82.58M | -718.01%-10.95M | --1.77M |
| -Other non-cash items | -148.91%-308.02M | -1.88%-123.75M | ---121.47M |
| Changes in working capital | -747.25%-563.05M | -138.60%-66.46M | --172.17M |
| -Change in receivables | 21.96%-259.13M | -3,500.37%-332.05M | --9.77M |
| -Change in inventory | -226.67%-233.5M | -19.38%-71.48M | ---59.87M |
| -Change in payables | -59.51%23.32M | 104.38%57.59M | --28.18M |
| -Provision for loans, leases and other losses | -78.24%19.65M | 996.13%90.29M | --8.24M |
| -Changes in other current assets | -159.93%-113.39M | 1.79%189.19M | --185.86M |
| Dividends paid (cash flow from operating activities) | |||
| Dividends received (cash flow from operating activities) | |||
| Interest paid (cash flow from operating activities) | 12.46%-24.76M | -52.76%-28.29M | -18.52M |
| Interest received (cash flow from operating activities) | -13.68%23.74M | 792.34%27.5M | 3.08M |
| Tax refund paid | 142.57%68.8M | -448.70%-161.62M | -29.46M |
| Other operating cash inflow (outflow) | 0.00%1K | 1K | 0 |
| Operating cash flow | -5,833.60%-927.9M | -104.79%-15.64M | --326.66M |
| Investing cash flow | |||
| Net PPE purchase and sale | -182.20%-674.29M | -105.29%-238.94M | ---116.39M |
| Net intangibles purchase and sale | 16.54%-211.8M | -445.33%-253.77M | ---46.54M |
| Net business purchase and sale | -216.70%-958.88M | 155.07%821.65M | ---1.49B |
| Net investment product transactions | -229.27%-259.44M | 219.16%200.69M | ---168.42M |
| Net changes in other investments | -2,411,400.00%-24.11M | 200.00%1K | ---1K |
| Investing cash flow | -501.89%-2.13B | 129.05%529.63M | ---1.82B |
| Financing cash flow | |||
| Net issuance payments of debt | -339.48%-395.51M | -125.35%-90M | --355M |
| Net common stock issuance | 454.12%2.5B | -83.32%450.65M | --2.7B |
| Net other fund-raising expenses | 342.62%29.82M | -100.67%-12.29M | --1.82B |
| Financing cash flow | 511.84%2.13B | -92.86%348.36M | --4.88B |
| Net cash flow | |||
| Beginning cash position | 20.02%5.01B | 425.46%4.17B | --794.23M |
| Current changes in cash | -207.26%-925M | -74.52%862.35M | --3.38B |
| Effect of exchange rate changes | 329.12%61.97M | -433.01%-27.05M | ---5.07M |
| Cash adjustments other than cash changes | ---1K | ---- | ---1K |
| End cash Position | -17.23%4.15B | 20.02%5.01B | --4.17B |
| Free cash flow | -251.07%-1.82B | -430.06%-519.29M | --157.33M |
| Currency Unit | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |